https://www.thebodypro.com/category/hiv-treatment-strategies/tag/conference-coverage
HIV Treatment Strategies

Conference Coverage

The Latest

How to Reverse Implicit Bias in HIV Care: 6 Steps to Take Today Img

How to Reverse Implicit Bias in HIV Care: 6 Steps to Take Today

We caught up with speakers and presenters at a major HIV community meeting to learn how HIV care providers can uncover and remove the harm of bias in their work.

Really Rapid Review -- Paris IAS 2017 Img

Really Rapid Review -- Paris IAS 2017

Paul Sax, M.D., recaps dozens of highlights from 9th International AIDS Society Conference on HIV Science.

CROI 2017: A View from My Seat at the Table Img

CROI 2017: A View from My Seat at the Table

"At CROI, the 'executive director hat' comes off, and I'm purely a community advocate again," Rob Newells writes. "This year, that was even more true than in previous years."

Implementation of a Rapid HIV Diagnostic and Referral Strategy Img

Implementation of a Rapid HIV Diagnostic and Referral Strategy

One study in Amsterdam deployed a strategy to identify acute HIV in men who have sex with men (MSM) and then link newly diagnosed individuals to care.

The Impact of HIV Health Literacy on Viral Suppression Img

The Impact of HIV Health Literacy on Viral Suppression

One factor that could help determine whether a person achieves an undetectable viral load is their health literacy, which is the measure of personal engagement and ability to seek medical care.

Dose Reduction Potential of Nanoparticle ARV Formulations Confirmed in Humans Img

Dose Reduction Potential of Nanoparticle ARV Formulations Confirmed in Humans

First in-human trial results of nanoformulations of efavirenz and lopinavir confirmed the potential for a 50% dose reduction to the current standard oral dose of both antiretrovirals.

Promo Image

Long-Acting HIV Treatment: 5 Myths and Realities

Long-acting antiretrovirals: Are they the future of HIV treatment or will the future pass them by? Researcher Charles W. Flexner recently addressed several common myths.

Capsules From CROI 2017 Img

Capsules From CROI 2017

Richard Jefferys analyzes key presentations from this year's Conference on Retroviruses and Opportunistic Infections.

HIV Clinical Trials Must Enroll More Women Img

HIV Clinical Trials Must Enroll More Women

"People who are designing the studies, who are funding the studies, need to make [enrolling women] a priority," says Rena Patel, M.D.

Weekly Injections of Antibody PRO 140 Keep HIV Undetectable in 10 of 16 Patients Img

Weekly Injections of Antibody PRO 140 Keep HIV Undetectable in 10 of 16 Patients

Self-injected monotherapy with PRO 140, a monoclonal antibody that binds to the CCR5 receptor on CD4 cells, maintained viral suppression in 10 of 16 study participants for 41 to 123 weeks.